Alumis, Inc. (ALMS)
25.50
-0.62
(-2.39%)
USD |
NASDAQ |
May 06, 16:00
25.50
0.00 (0.00%)
After-Hours: 16:07
Alumis Total Liabilities (Quarterly) : 114.84M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 66.37B |
| Nektar Therapeutics | 190.57M |
| Oramed Pharmaceuticals, Inc. | 31.12M |
| Aclaris Therapeutics, Inc. | 57.38M |
| Crinetics Pharmaceuticals, Inc. | 143.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 416.14M |
| Shareholders Equity (Quarterly) | 301.30M |
| Debt to Equity Ratio | 0.1225 |
| Current Ratio | 4.340 |
| Net Debt Paydown Yield | -0.11% |